X-139541073-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4

The NM_000133.4(F9):​c.278-3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000936 in 1,068,145 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 9.4e-7 ( 0 hom. 0 hem. )

Consequence

F9
NM_000133.4 splice_region, intron

Scores

2
Splicing: ADA: 0.9254
2

Clinical Significance

Pathogenic criteria provided, single submitter P:2O:1

Conservation

PhyloP100: 1.53

Publications

1 publications found
Variant links:
Genes affected
F9 (HGNC:3551): (coagulation factor IX) This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Sep 2015]
F9 Gene-Disease associations (from GenCC):
  • hemophilia B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • mild hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • moderately severe hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • severe hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of hemophilia B in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • thrombophilia, X-linked, due to factor 9 defect
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-139541073-A-G is Pathogenic according to our data. Variant chrX-139541073-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 92225.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F9NM_000133.4 linkc.278-3A>G splice_region_variant, intron_variant Intron 3 of 7 ENST00000218099.7 NP_000124.1
F9NM_001313913.2 linkc.277+3687A>G intron_variant Intron 3 of 6 NP_001300842.1
F9XM_005262397.5 linkc.278-3A>G splice_region_variant, intron_variant Intron 3 of 6 XP_005262454.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F9ENST00000218099.7 linkc.278-3A>G splice_region_variant, intron_variant Intron 3 of 7 1 NM_000133.4 ENSP00000218099.2
F9ENST00000394090.2 linkc.277+3687A>G intron_variant Intron 3 of 6 1 ENSP00000377650.2
F9ENST00000479617.2 linkn.242-14A>G intron_variant Intron 2 of 3 5

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
9.36e-7
AC:
1
AN:
1068145
Hom.:
0
Cov.:
26
AF XY:
0.00
AC XY:
0
AN XY:
339217
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25654
American (AMR)
AF:
0.00
AC:
0
AN:
34637
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18631
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53480
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39181
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3993
European-Non Finnish (NFE)
AF:
0.00000122
AC:
1
AN:
818966
Other (OTH)
AF:
0.00
AC:
0
AN:
44509
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary factor IX deficiency disease Pathogenic:1Other:1
Nov 06, 2009
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

SNPedia
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Pathogenic:1
Mar 29, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. This sequence change falls in intron 3 of the F9 gene. It does not directly change the encoded amino acid sequence of the F9 protein, but it affects a nucleotide within the consensus splice site of the intron. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with hemophilia B (PMID: 28834196, 18624698, 8434583). This variant is also known as IVS3-3A>G and 10389A>G. ClinVar contains an entry for this variant (Variation ID: 92225). Experimental studies have shown that this variant disrupts mRNA splicing and is expected to lead to the loss of protein expression (PMID: 19815722, 28834196).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
22
DANN
Benign
0.85
PhyloP100
1.5
Mutation Taster
=8/92
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.93
dbscSNV1_RF
Benign
0.47
SpliceAI score (max)
0.44
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.44
Position offset: 1
DS_AL_spliceai
0.35
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398122990; hg19: chrX-138623232; API